共 428 条
[1]
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]
Bray F(2002)Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer Urology 60 7-11
[3]
Center MM(2009)Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2516-2527
[4]
Ferlay J(2011)EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 59 572-583
[5]
Ward E(2012)Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 62 220-241
[6]
Forman D(2008)Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer BJU Int 102 44-47
[7]
Meng MV(2008)Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation Prostate Cancer Prostatic Dis 12 198-203
[8]
Grossfeld GD(2008)Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy Urology 72 422-427
[9]
Sadetsky N(2007)Fracture risk in Danish men with prostate cancer: a nationwide register study BJU Int 100 749-754
[10]
Mehta SS(2006)Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy J Clin Oncol Off J Am Soc Clin Oncol 24 3979-3983